JP2018513680A5 - - Google Patents

Info

Publication number

JP2018513680A5

JP2018513680A5 JP2017549723A JP2017549723A JP2018513680A5 JP 2018513680 A5 JP2018513680 A5 JP 2018513680A5 JP 2017549723 A JP2017549723 A JP 2017549723A JP 2017549723 A JP2017549723 A JP 2017549723A JP 2018513680 A5 JP2018513680 A5 JP 2018513680A5

Authority

JP

Japan

Prior art keywords

seq

fragment

hbv

binding

binding molecule

Prior art date

2016-03-25

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 239000012634 fragment Substances 0.000 claims description 109
• 241000700721 Hepatitis B virus Species 0.000 claims description 91
• 239000000427 antigen Substances 0.000 claims description 57
• 102000036639 antigens Human genes 0.000 claims description 56
• 108091007433 antigens Proteins 0.000 claims description 56
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 47
• 210000004027 cell Anatomy 0.000 claims description 46
• 101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 claims description 40
• 102100029571 Immunoglobulin J chain Human genes 0.000 claims description 40
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 34
• 239000002245 particle Substances 0.000 claims description 29
• 229920001184 polypeptide Polymers 0.000 claims description 28
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 28
• 238000000034 method Methods 0.000 claims description 22
• 208000015181 infectious disease Diseases 0.000 claims description 20
• 230000002458 infectious effect Effects 0.000 claims description 17
• 108091033319 polynucleotide Proteins 0.000 claims description 16
• 102000040430 polynucleotide Human genes 0.000 claims description 16
• 239000002157 polynucleotide Substances 0.000 claims description 16
• 230000003612 virological effect Effects 0.000 claims description 16
• 239000000203 mixture Substances 0.000 claims description 11
• 208000006454 hepatitis Diseases 0.000 claims description 10
• 230000003389 potentiating effect Effects 0.000 claims description 9
• 102000013463 Immunoglobulin Light Chains Human genes 0.000 claims description 8
• 108010065825 Immunoglobulin Light Chains Proteins 0.000 claims description 8
• 201000010099 disease Diseases 0.000 claims description 8
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 8
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 8
• 238000006467 substitution reaction Methods 0.000 claims description 8
• 150000001875 compounds Chemical class 0.000 claims description 6
• 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 6
• 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 6
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 5
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 4
• 231100000283 hepatitis Toxicity 0.000 claims description 4
• 150000007523 nucleic acids Chemical group 0.000 claims description 4
• 206010008909 Chronic Hepatitis Diseases 0.000 claims description 3
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 claims description 3
• 101001055311 Equus asinus Immunoglobulin heavy constant alpha Proteins 0.000 claims description 3
• 206010016654 Fibrosis Diseases 0.000 claims description 3
• 206010019663 Hepatic failure Diseases 0.000 claims description 3
• 101000946860 Homo sapiens T-cell surface glycoprotein CD3 epsilon chain Proteins 0.000 claims description 3
• 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 claims description 3
• 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 claims description 3
• 102000017727 Immunoglobulin Variable Region Human genes 0.000 claims description 3
• 108010067060 Immunoglobulin Variable Region Proteins 0.000 claims description 3
• 102100035794 T-cell surface glycoprotein CD3 epsilon chain Human genes 0.000 claims description 3
• 231100000354 acute hepatitis Toxicity 0.000 claims description 3
• 230000007882 cirrhosis Effects 0.000 claims description 3
• 208000019425 cirrhosis of liver Diseases 0.000 claims description 3
• 239000000539 dimer Substances 0.000 claims description 3
• 231100000835 liver failure Toxicity 0.000 claims description 3
• 208000007903 liver failure Diseases 0.000 claims description 3
• 238000012423 maintenance Methods 0.000 claims description 3
• 101710132601 Capsid protein Proteins 0.000 claims description 2
• 208000037319 Hepatitis infectious Diseases 0.000 claims description 2
• 230000002708 enhancing effect Effects 0.000 claims description 2
• 208000005252 hepatitis A Diseases 0.000 claims description 2
• 230000002401 inhibitory effect Effects 0.000 claims description 2
• 230000035755 proliferation Effects 0.000 claims description 2
• 239000008194 pharmaceutical composition Substances 0.000 claims 6
• 210000004899 c-terminal region Anatomy 0.000 claims 2
• 230000005764 inhibitory process Effects 0.000 claims 1
• 239000013598 vector Substances 0.000 description 7
• 241000700605 Viruses Species 0.000 description 4
• 150000001413 amino acids Chemical class 0.000 description 3
• 230000001276 controlling effect Effects 0.000 description 3
• 208000004998 Abdominal Pain Diseases 0.000 description 2
• 208000006820 Arthralgia Diseases 0.000 description 2
• 206010023126 Jaundice Diseases 0.000 description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 description 2
• 206010037660 Pyrexia Diseases 0.000 description 2
• 206010047700 Vomiting Diseases 0.000 description 2
• 230000004596 appetite loss Effects 0.000 description 2
• 210000005260 human cell Anatomy 0.000 description 2
• 208000019017 loss of appetite Diseases 0.000 description 2
• 235000021266 loss of appetite Nutrition 0.000 description 2
• 208000024891 symptom Diseases 0.000 description 2
• 210000002700 urine Anatomy 0.000 description 2
• 230000007485 viral shedding Effects 0.000 description 2
• 102400001107 Secretory component Human genes 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 208000002672 hepatitis B Diseases 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1